{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:09:16Z","timestamp":1791083356491,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2320-B110-003"],"award-info":[{"award-number":["NSTC112-2320-B110-003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bcp.2023.115738","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T20:58:24Z","timestamp":1691528304000},"page":"115738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells"],"prefix":"10.1016","volume":"215","author":[{"given":"Jing-Ting","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2023.115738_b0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.bcp.2023.115738_b0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115738_b0015","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/febs.13190","article-title":"BH3-only proteins: a 20-year stock-take","volume":"282","author":"Doerflinger","year":"2015","journal-title":"FEBS J."},{"issue":"1-2","key":"10.1016\/j.bcp.2023.115738_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2023.115738_b0025","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1158\/2159-8290.CD-21-1334","article-title":"Adapted to survive: targeting cancer cells with BH3 mimetics","volume":"12","author":"Montero","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bcp.2023.115738_b0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2023.115738_b0035","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/s41467-018-05815-z","article-title":"Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity","volume":"9","author":"Soderquist","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2023.115738_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109978","article-title":"BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells","volume":"361","author":"Chiou","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2023.115738_b0045","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/s41467-019-10363-1","article-title":"Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations","volume":"10","author":"Birkinshaw","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2023.115738_b0050","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acsmedchemlett.9b00568","article-title":"Discovery of A-1331852, a first-in-class, potent, and orally-bioavailable BCL-XL inhibitor","volume":"11","author":"Wang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bcp.2023.115738_b0055","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tips.2020.09.004","article-title":"BH3 mimetics in AML therapy: death and beyond?","volume":"41","author":"Cerella","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2023.115738_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2018.06.019","article-title":"ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells","volume":"432","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2023.115738_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114047","article-title":"Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation","volume":"178","author":"Lee","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115738_b0070","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41419-020-02867-2","article-title":"Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition","volume":"11","author":"Roca-Portoles","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2023.115738_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110374","article-title":"BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer","volume":"38","author":"Ramesh","year":"2022","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.bcp.2023.115738_b0080","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.18632\/oncotarget.7204","article-title":"Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines","volume":"7","author":"Koss","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2023.115738_b0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41419-019-1426-3","article-title":"Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477","volume":"10","author":"Mallick","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2023.115738_b0090","doi-asserted-by":"crossref","first-page":"279ra40","DOI":"10.1126\/scitranslmed.aaa4642","article-title":"Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy","volume":"7","author":"Leverson","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115738_b0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115738_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.taap.2015.02.005","article-title":"Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK\/c-Jun-mediated BCL2L1 expression","volume":"284","author":"Changchien","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115738_b0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2018.09.008","article-title":"The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells","volume":"358","author":"Chen","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115738_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115442","article-title":"AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK\/miR-22\/HuR axis in chronic myeloid leukemia cells","volume":"209","author":"Lee","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115738_b0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2017.08.019","article-title":"Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3\/miR-183\/\u03b2-TrCP\/SP1 axis-mediated BAX upregulation","volume":"334","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115738_b0120","first-page":"2977","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"BBA"},{"issue":"9","key":"10.1016\/j.bcp.2023.115738_b0125","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.cellsig.2013.05.021","article-title":"Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit \u03b1 and MAPK phosphatase-1 expression in human leukemia U937 cells","volume":"25","author":"Liu","year":"2013","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2023.115738_b0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis*","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2023.115738_b0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41418-019-0391-9","article-title":"BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics","volume":"27","author":"Villalobos-Ortiz","year":"2020","journal-title":"Cell Death Differ."},{"issue":"11","key":"10.1016\/j.bcp.2023.115738_b0140","doi-asserted-by":"crossref","first-page":"10491","DOI":"10.1074\/jbc.M412819200","article-title":"Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells","volume":"280","author":"Weng","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2023.115738_b0145","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1177\/1535370214538745","article-title":"Caspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell lines","volume":"239","author":"Ryu","year":"2014","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bcp.2023.115738_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115013","article-title":"Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells","volume":"397","author":"Huang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115738_b0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41418-019-0486-3","article-title":"Saga of Mcl-1: regulation from transcription to degradation","volume":"27","author":"Senichkin","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2023.115738_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115847","article-title":"CREB\/Sp1-mediated MCL1 expression and NF\u03baB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells","volume":"435","author":"Chiou","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115738_b0165","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/carcin\/bgs409","article-title":"p38 MAPK\/PP2Ac\u03b1\/TTP pathway on the connection of TNF-\u03b1 and caspases activation on hydroquinone-induced apoptosis","volume":"34","author":"Liu","year":"2013","journal-title":"Carcinogenesis"},{"issue":"23","key":"10.1016\/j.bcp.2023.115738_b0170","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4161\/15384101.2014.965068","article-title":"The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling","volume":"13","author":"Xu","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2023.115738_b0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2023.115738_b0180","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1038\/ncomms9048","article-title":"Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A","volume":"6","author":"Wong","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2023.115738_b0185","doi-asserted-by":"crossref","first-page":"L1005","DOI":"10.1152\/ajplung.2000.279.6.L1005","article-title":"Reactive oxygen species in cell signaling","volume":"279","author":"Thannickal","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115738_b0190","first-page":"1","article-title":"Pathophysiological roles of ASK1-MAP kinase signaling pathways","volume":"40","author":"Nagai","year":"2007","journal-title":"J. Biochem. Mol. Biol."},{"issue":"13","key":"10.1016\/j.bcp.2023.115738_b0195","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1074\/jbc.M209108200","article-title":"Persistent ERK phosphorylation negatively regulates cAMP response element-binding protein (CREB) activity via recruitment of CREB-binding protein to pp90RSK","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115738_b0200","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jcp.22180","article-title":"Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+\/ROS-mediated suppression of ERK\/c-fos pathway and activation of p38 MAPK\/c-jun pathway","volume":"224","author":"Liu","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2023.115738_b0205","article-title":"Effects of SIDT2 on the miR-25\/NOX4\/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF-\u03b1 expression in hydroquinone-treated leukemia cells","author":"Wang","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2023.115738_b0210","first-page":"2822","article-title":"Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation","volume":"13","author":"Wadzinski","year":"1993","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115738_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100908","article-title":"Roles of constitutive and signal-dependent protein phosphatase 2A docking motifs in burst attenuation of the cyclic AMP response element-binding protein","volume":"297","author":"Kim","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115738_b0220","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.1102041","article-title":"IFN-\u03b3 elicits macrophage autophagy via the p38 MAPK signaling pathway","volume":"189","author":"Matsuzawa","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115738_b0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","article-title":"p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents","volume":"344","author":"Sui","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2023.115738_b0230","doi-asserted-by":"crossref","first-page":"e05289","DOI":"10.7554\/eLife.05289","article-title":"The stress-responsive kinases MAPKAPK2\/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation","volume":"4","author":"Wei","year":"2015","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.bcp.2023.115738_b0235","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1080\/15548627.2021.1912270","article-title":"CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"issue":"23","key":"10.1016\/j.bcp.2023.115738_b0240","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1073\/pnas.1406425111","article-title":"Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak","volume":"111","author":"Lindqvist","year":"2014","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.bcp.2023.115738_b0245","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/15548627.2016.1179406","article-title":"BAX-BAK1-independent LC3B lipidation by BH3 mimetics is unrelated to BH3 mimetic activity and has only minimal effects on autophagic flux","volume":"12","author":"Reljic","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2023.115738_b0250","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.2147\/OTT.S281519","article-title":"BCL-2 Inhibitor venetoclax induces autophagy-associated cell death, cell cycle arrest, and apoptosis in human breast cancer cells","volume":"13","author":"Alhoshani","year":"2020","journal-title":"Oncol. Targets Ther."},{"key":"10.1016\/j.bcp.2023.115738_b0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41420-022-01211-1","article-title":"BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia","volume":"8","author":"Parry","year":"2022","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.bcp.2023.115738_b0260","article-title":"It's time to die: BH3 mimetics in solid tumors","volume":"1868","author":"Kehr","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.bcp.2023.115738_b0265","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1101\/gad.215855.113","article-title":"Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction","volume":"27","author":"Wang","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2023.115738_b0270","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s42003-021-02564-6","article-title":"The multiple mechanisms of MCL1 in the regulation of cell fate","volume":"4","author":"Widden","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2023.115738_b0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41419-021-04334-y","article-title":"MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma","volume":"13","author":"Fu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"32","key":"10.1016\/j.bcp.2023.115738_b0280","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1038\/s41388-018-0268-2","article-title":"Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition","volume":"37","author":"Weeden","year":"2018","journal-title":"Oncogene"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223003295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223003295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:54:05Z","timestamp":1757771645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":56,"alternative-id":["S0006295223003295"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115738","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115738"}}